Flow cytometry analyses of sorted patient-derived primary BM B-ALL cell subpopulations, including CD34+CD19−-progenitors, CD34+CD19+-Pro B and CD34−CD19+-stages, showed heterogeneous cortactin expression among patients and lineage differentiation (Suppl. This evidence concerns the gene CTTN and acute lymphoblastic leukemia.